Results 91 to 100 of about 4,842,469 (101)

Once-Daily, Subcutaneous Vosoritide Therapy in Children With Achondroplasia: A Randomised, Double-Blind, Phase 3, Placebo-Controlled, Multicentre Trial

Lancet, The, 2020
Paul Harmatz, Klane K White
exaly  

Growth in Achondroplasia: Development of Height, Weight, Head Circumference, and Body Mass Index in a European Cohort

American Journal of Medical Genetics, Part A, 2018
Klaus Mohnike, Giedre Grigelioniene, Outi Mäkitie   +2 more
exaly  

A European Tobacco Advertising Ban

Ca-A Cancer Journal for Clinicians, 1998
J R Seffrin
exaly  

Commentary on “European Consensus Statement on Lung Cancer”

Ca-A Cancer Journal for Clinicians, 1998
Dileep G Bal
exaly  

European Consensus Statement on Lung Cancer: Risk Factors and Prevention. Lung Cancer Panel

Ca-A Cancer Journal for Clinicians, 1998
Hans Konrad Biesalski, Ugo Pastorino, A Chesson   +2 more
exaly  

Vosoritide, a Miracle Drug, Covering Unmet Need in Achondroplasia: A Regulatory Update

Intractable and Rare Diseases Research, 2023
exaly  

Novel Therapeutic Approaches for the Treatment of Achondroplasia

Bone, 2020
Ravi Savarirayan, Laurence Legeai-Mallet
exaly  

The Molecular and Genetic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome With Acanthosis Nigricans

Endocrine Reviews, 2000
Clair A. Francomano, Zoltan Vajo
exaly  

Achondroplasia

Best Practice and Research in Clinical Rheumatology, 2008
Genevieve Baujat, Valérie Cormier-Daire, Laurence Legeai-Mallet   +2 more
exaly  

Mutations in Fibroblast Growth-Factor Receptor 3 in Sporadic Cases of Achondroplasia Occur Exclusively on the Paternally Derived Chromosome

American Journal of Human Genetics, 1998
Arnold Munnich, Clair A. Francomano, Gary A Bellus   +2 more
exaly